The Belfast Health and Social Care Trust is a health organisation covering Belfast, Northern Ireland. The trust is one of five new trusts which were created on 1 April 2007 by the then Department of Health, Social Services and Public Safety. The Belfast Trust employs 22,000 staff.

During the past decade, Belfast Health and Social Care Trust conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 8 clinical trials were completed, i.e. on average, 14.5% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 7 clinical trials were completed. i.e. 30.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Belfast Health and Social Care Trust" #1 sponsor was "Belfast Health and Social Care Trust" with 9 trials, followed by "Queen's University, Belfast" with 7 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Celgene" with 3 trials sponsored and "Medtronic Cardiovascular" with 3 trials sponsored. Other sponsors include 43 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Belfast Health and Social Care Trust" #1 collaborator was "Belfast Health and Social Care Trust" with 8 trials as a collaborator, "Queen's University, Belfast" with 5 trials as a collaborator, "Northern Ireland Clinical Trials Unit" with 4 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator and "Medical Research Council" with 3 trials as a collaborator. Other collaborators include 105 different institutions and companies that were collaborators in the rest 99 trials.

According to Clinical.Site data, the most researched conditions in "Belfast Health and Social Care Trust" are "Coronary Artery Disease" (4 trials), "Prostate Cancer" (4 trials), "Diabetic Macular Edema" (3 trials), "Heart Failure" (3 trials) and "Acute Coronary Syndrome" (2 trials). Many other conditions were trialed in "Belfast Health and Social Care Trust" in a lesser frequency.

Most popular intervention types in "Belfast Health and Social Care Trust" are "Drug" (36 trials), "Procedure" (13 trials), "Other" (12 trials), "Device" (11 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Faricimab" (4 trials), "Sham Procedure" (4 trials), "vincristine sulfate" (4 trials) and "Aflibercept" (3 trials). Other intervention names were less common.

The vast majority of trials in "Belfast Health and Social Care Trust" are 67 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Belfast Health and Social Care Trust". undefined are not yet recruiting, 17 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Belfast Health and Social Care Trust, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Belfast Health and Social Care Trust, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 18 trials that are defined as “Not Applicable".